Data / Research funding / California / Molecular Express, Inc.
Molecular Express, Inc.: 10 NIH awards ($13.8M), fiscal years 2021 to 2026
Molecular Express, Inc. in Rancho Dominguez, CA is funded under 10 NIH awards ($13.8M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- R1JMHFESEKD5
- State
- California
Awards
10 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| VESIVAX TLR7 FORMULA | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $2,999,352 | September 1, 2024 | August 31, 2027 | HO, SAMON | reporter.nih.gov |
| Development of a VesiVax HIV Vaccine Formulation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $2,294,565 | August 1, 2022 | July 31, 2024 | ON HO, SAM | reporter.nih.gov |
| Non-clinical Development of a Synthetic Lung Surfactant for Treatment of NRDS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,169,278 | August 1, 2021 | May 31, 2023 | FUJII, GARY | reporter.nih.gov |
| Design and Engineering of VesiVax HIV Immunogen Formulations | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $1,999,866 | July 1, 2024 | June 30, 2026 | HO, SAMON | reporter.nih.gov |
| Preclinical Development of a ME-1001, a Synthetic Lung Surfactant | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,999,637 | May 15, 2024 | October 31, 2026 | FUJII, GARY | reporter.nih.gov |
| DEVELOPMENT OF VESIVAX CO-ADJUVANT FORMULATION OF 2E151 for flu vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $599,925 | September 30, 2023 | September 29, 2025 | ONHO, SAM | reporter.nih.gov |
| VesiVax Vaccine Formulation Against Neisseria gonorrhoeae | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $599,596 | February 18, 2022 | January 31, 2025 | FUJII, GARY | reporter.nih.gov |
| DEVELOPMENT OF A VESIVAS IMMUNOSIMILAR FORMULATION | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $569,807 | August 1, 2021 | July 31, 2023 | FUJII, GARY | reporter.nih.gov |
| VesiVax HIVgp41e Vaccine Design | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $300,000 | July 1, 2022 | June 30, 2023 | FUJI, GARY | reporter.nih.gov |
| Niclosamide Formulations for the Treatment of Influenza Infections | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $298,479 | July 8, 2022 | June 30, 2023 | FUJII, GARY | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 1 | $999,784 | 0 | $0 |
| 2024 | 3 | $5,999,071 | 0 | $0 |
| 2023 | 2 | $899,704 | 0 | $0 |
| 2022 | 5 | $4,105,256 | 0 | $0 |
| 2021 | 3 | $1,826,690 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 2 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 2 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 2 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 2 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 2 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.838 | December 3, 2026 | Not listed | Same assistance listing 93.838 as 2 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.838 | December 3, 2026 | Not listed | Same assistance listing 93.838 as 2 awards here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.838 | December 4, 2026 | Not listed | Same assistance listing 93.838 as 2 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.838 | January 5, 2027 | Not listed | Same assistance listing 93.838 as 2 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.838 | January 5, 2027 | Not listed | Same assistance listing 93.838 as 2 awards here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.838 | January 7, 2027 | $375,000 | Same assistance listing 93.838 as 2 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.838 | January 7, 2027 | Not listed | Same assistance listing 93.838 as 2 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 2 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 2 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 2 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 2 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 2 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 2 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 2 awards here |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) | PAR-25-025 | NIH | 93.838 | February 3, 2027 | $1.5 million | Same assistance listing 93.838 as 2 awards here |
Topics of its NIH awards
- Infectious Diseases
- Immunization
- Vaccine Related
- Prevention
- Biotechnology
- Lung
- Emerging Infectious Diseases
- Neonatal Respiratory Distress
- Pediatric
- Perinatal Period - Conditions Originating in Perinatal Period
- Preterm, Low Birth Weight and Health of the Newborn
- Bioengineering
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.